1
Taffy Williams, George Tuszynski, Paul Actor: Retroinverso polypeptides that mimic or inhibit thrombospondin activity. Inkine Pharmaceutical Company, Finnegan Henderson Farabow Garrett & Dunner L, January 15, 2002: US06339062 (6 worldwide citation)

The present invention relates generally to polypeptides that mimic or inhibit the biological activity of thrombospondin, and particularly to polypeptides in retroinverso form. These polypeptides may be used for their biological and pharmaceutical applications such as: (a) inhibiting the invasive and ...


2
Taffy Williams, George Tuszynski, Paul Actor: Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions. Inkine Pharmaceutical Company, Philadelphia Health and Education Corporation, Finnegan Henderson Farabow Garrett & Dunner L, April 30, 2002: US06380161 (3 worldwide citation)

The present invention provides methods and compositions for treating cancer and chemotherapy-resistant cancers comprising a chemotherapeutic agent conjugated to or coadministered with a peptide.


3
George P Tuszynski, John F Wong, Taffy Williams: Administration of angiocidin for arresting the growth of a tumor cell. Temple University of the Commonwealth System of Higher Education, Riverside Law, December 27, 2016: US09526758

Methods are presented for the therapeutic administration of angiocidin in the treatment of cancers such as glioma, breast cancer, and leukemia. Methods are also presented for inducing growth arrest and/or apoptosis of tumor cells, as well as inducing differentiation of tumor cells to inhibit tumorig ...


4
George Tuszynski, Taffy Williams: Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor. Philadelphia Health and Education Corporation, Finnegan Henderson Farabow Garrett & Dunner, September 25, 2003: US20030180295-A1

The present invention provides the sequence of a cell matrix receptor specific for the Cys-Ser-Val-Thr-Cys-Gly (SEQ ID NO: 1) region of thrombospondin. Also provided are purification, cloning and expression methods. The receptor protein is useful in numerous diagnostic, prophylactic and therapeutic ...


5
Taffy Williams, George Tuszynski, Paul Actor: Retroinverso polypeptides that mimic or inhibit thrombospondin. Inkine Pharmaceuticals Mcp Hahnemann, Finnegan Henderson Farabow Garrett & Dunner, September 11, 2003: US20030171298-A1

The present invention relates generally to polypeptides that mimic or inhibit the biological activity of thrombospondin, and particularly to polypeptides in retroinverso form. The peptides. These polypeptides may be used biological and pharmaceutical applications such as: (a) inhibiting the invasive ...


6
George P Tuszynski, John F Wong, Taffy Williams: Administration of angiocidin for the treatment of cancer. Temple University Of The Commonwealth System Of Higher Education, November 24, 2011: US20110288021-A1

Methods are presented for the therapeutic administration of angiocidin in the treatment of cancers such as glioma, breast cancer, and leukemia. Methods are also presented for inducing growth arrest and/or apoptosis of tumor cells, as well as inducing differentiation of tumor cells to inhibit tumorig ...



Click the thumbnails below to visualize the patent trend.